Adial Pharmaceuticals Files 8-K on Shareholder Nominations
Ticker: ADIL · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-action
TL;DR
Adial Pharma filed an 8-K about shareholder nominations - board shakeup incoming?
AI Summary
Adial Pharmaceuticals, Inc. filed an 8-K on June 16, 2025, reporting on shareholder nominations pursuant to Exchange Act Rule 14a-11 and other events. The company, incorporated in Delaware, is based in Glen Allen, VA.
Why It Matters
This filing indicates potential changes or discussions regarding the company's board of directors, which could impact its strategic direction.
Risk Assessment
Risk Level: medium — Filings related to shareholder nominations and board composition can signal potential shifts in company strategy or governance.
Key Players & Entities
- Adial Pharmaceuticals, Inc. (company) — Registrant
- June 16, 2025 (date) — Date of Report
- Exchange Act Rule 14a-11 (regulation) — Subject of filing
- Delaware (jurisdiction) — State of Incorporation
- Glen Allen, VA (location) — Principal Executive Offices
FAQ
What specific shareholder nominations were made or discussed in this filing?
The filing mentions shareholder nominations pursuant to Exchange Act Rule 14a-11 but does not detail the specific nominations within the provided text.
What are the 'Other Events' referenced in the filing?
The filing indicates 'Other Events' were reported but does not specify what those events are in the provided text.
When was Adial Pharmaceuticals, Inc. incorporated?
Adial Pharmaceuticals, Inc. was incorporated in Delaware.
What is the principal executive office address for Adial Pharmaceuticals, Inc.?
The principal executive offices are located at 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.
What is the Commission File Number for Adial Pharmaceuticals, Inc.?
The Commission File Number for Adial Pharmaceuticals, Inc. is 001-38323.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).